An investment in Voyageur provides a direct and rare opportunity for exposure in a radiology pharmaceutical company, that is working towards full integration of its supply chain. Upon successful execution, Voyageur will be the only company in the market place that controls all cost. By owning its own feed stock ingredients, extracting them from the earth and refining them into pharmaceutical active pharmaceutical ingredients (API).
FROM THE EARTH TO THE BOTTLE
For further information, please contact us.